SEC Form 4 · accession 0001144204-15-003458
Arch Therapeutics, Inc. · ARTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Terrence W Norchi
Officer — President & CEO · Director · 10% Owner
Period of report
Jan 22, 2015
Accepted (ET)
Jan 23, 2015 · 12:39 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001537561
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $0.19 | Jan 22, 2015 | A | 400,000 | A | — | Jan 21, 2025 | Common Stock | 400,000 | 400,000 | D |
Explanation of responses
- F1Of the Shares subject to the Option, 25% shall vest immediately, 25% shall vest twelve (12) months after the Vesting Commencement Date, and 1/24 of the remaining unvested Shares subject to the Option shall vest on each of the next twenty four (24) monthly anniversaries of the Vesting Commencement Date thereafter.